NCT04943536View on ClinicalTrials.gov

Bicalutamide Implants (Biolen) With Radiation Therapy in Patients With Localized Prostate Cancer

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

May 15, 2027

Study Completion Date

August 15, 2027

Conditions
Prostate Adenocarcinoma
Interventions
DRUG

bicalutamide

localized anti-androgen therapy

RADIATION

Stereotactic body radiation therapy

localized radiation therapy

Trial Locations (1)

20894

National Cancer Institute, Bethesda

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alessa Therapeutics Inc.

INDUSTRY